Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study

Petter Tinghög1, Charlotte Björkenstam, John Carstensen

  • 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. petter.tinghog@ki.se.

BMC Neurology
|June 5, 2014
PubMed
Abstract

Insights

Co-existing mental disorders significantly increase the risk of disability pension for multiple sclerosis (MS) patients. This highlights the importance of managing comorbidities in MS care.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic, disabling neurological condition.
  • In Sweden, 62% of MS patients aged 16-65 were on disability pension in 2005.
  • Comorbidities may exacerbate disability and impact employment status in MS patients.

Purpose of the Study:

  • To investigate if common comorbidities increase disability pension risk in MS patients.
  • To analyze the impact of mental, musculoskeletal, and cardiovascular disorders on disability pension.
  • To identify synergistic effects of comorbidities on disability pension risk.

Main Methods:

  • Population-based cohort study of 4,519 MS patients and 4,972,174 non-MS individuals in Sweden (2005).
  • Utilized nationwide registers to identify MS patients and assess comorbidities (musculoskeletal, mental, cardiovascular).
  • Employed time-dependent proportional hazard models with a five-year follow-up, adjusting for socio-demographic factors.

Main Results:

  • Elevated prevalence of all studied disorders among MS patients.
  • MS patients with mental disorders showed a significantly higher risk for disability pension.
  • Mental disorders exhibited a synergistic effect on disability pension risk in MS patients.
  • Musculoskeletal disorders showed a potential increase in disability pension risk, but synergy was inconclusive.
  • Cardiovascular comorbidity did not significantly influence disability pension risk.

Conclusions:

  • Comorbidities, particularly mental disorders, substantially elevate disability pension risk in multiple sclerosis.
  • These findings underscore the critical role of managing comorbidities in MS patient care and treatment strategies.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
51